Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
8 February 2021 |
Main ID: |
NCT00878943 |
Date of registration:
|
08/04/2009 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Open Label Access Study Of Sildenafil In Adult Patients With Pulmonary Arterial Hypertension Completing A1481244 Study
UK 92480 |
Scientific title:
|
A Local, Multi-centre, Open Label Access Study, To Provide Sildenafil Therapy To Eligible Adult Patients With Pulmonary Arterial Hypertension Completing A1481244 Study In India Or Ongoing In A1481269 Study Who Continue To Receive Benefit From Sildenafil Therapy. |
Date of first enrolment:
|
March 31, 2009 |
Target sample size:
|
|
Recruitment status: |
No longer available |
URL:
|
https://clinicaltrials.gov/show/NCT00878943 |
Study type:
|
Expanded Access |
Study design:
|
|
Phase:
|
|
|
Countries of recruitment
|
India
| | | | | | | |
Contacts
|
Name:
|
Pfizer CT.gov Call Center |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Pfizer |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Subject who complete the A1481244 study and require Sildenafil (Revatio TM) 20 mg TID
therapy.
- All women of childbearing potential must use adequate contraception throughout the
study and four weeks after completion of the study
Exclusion Criteria:
- Pregnant or lactating women
- Participation in other studies during study participation
- Other severe acute or chronic medical or psychiatric condition or laboratory
abnormality that may increase the risk associated with study participation
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Pulmonary Arterial Hypertension
|
Intervention(s)
|
Drug: Sildenafil citrate
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|